Report Detail
Global Noninvasive Prenatal Gene Testing Technology Market Growth (Status and Outlook) 2022-2028
- RnM4484219 |
- 19 August, 2022 |
- Global |
- 112 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
The global market for Noninvasive Prenatal Gene Testing Technology is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Noninvasive Prenatal Gene Testing Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Noninvasive Prenatal Gene Testing Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Noninvasive Prenatal Gene Testing Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Noninvasive Prenatal Gene Testing Technology market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Noninvasive Prenatal Gene Testing Technology players cover Illumina, Natera, LifeLabs, NiftyTest and Labcorp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Noninvasive Prenatal Gene Testing Technology market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Noninvasive Prenatal Gene Testing Technology market, with both quantitative and qualitative data, to help readers understand how the Noninvasive Prenatal Gene Testing Technology market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Noninvasive Prenatal Gene Testing Technology market and forecasts the market size by Type (NIPT and NIPT Plus,), by Application (Chromosomal Abnormalities, Assisted Reproduction and Others,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
NIPT
NIPT Plus
Segmentation by application
Chromosomal Abnormalities
Assisted Reproduction
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Illumina
Natera
LifeLabs
NiftyTest
Labcorp
Xcelom
Veritas
Sema4
CeGaT
BGI
Berry Genomics
Daan Gene
CapitalBio
Annoroad
Adicon
Chapter Introduction
Chapter 1: Scope of Noninvasive Prenatal Gene Testing Technology, Research Methodology, etc.
Chapter 2: Executive Summary, global Noninvasive Prenatal Gene Testing Technology market size and CAGR, Noninvasive Prenatal Gene Testing Technology market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Noninvasive Prenatal Gene Testing Technology revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Noninvasive Prenatal Gene Testing Technology revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Noninvasive Prenatal Gene Testing Technology market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Illumina, Natera, LifeLabs, NiftyTest, Labcorp, Xcelom, Veritas, Sema4 and CeGaT, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Noninvasive Prenatal Gene Testing Technology Market Size 2017-2028
- 2.1.2 Noninvasive Prenatal Gene Testing Technology Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Noninvasive Prenatal Gene Testing Technology Segment by Type
- 2.2.1 NIPT
- 2.2.2 NIPT Plus
- 2.3 Noninvasive Prenatal Gene Testing Technology Market Size by Type
- 2.3.1 Noninvasive Prenatal Gene Testing Technology Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Noninvasive Prenatal Gene Testing Technology Market Size Market Share by Type (2017-2022)
- 2.4 Noninvasive Prenatal Gene Testing Technology Segment by Application
- 2.4.1 Chromosomal Abnormalities
- 2.4.2 Assisted Reproduction
- 2.4.3 Others
- 2.5 Noninvasive Prenatal Gene Testing Technology Market Size by Application
- 2.5.1 Noninvasive Prenatal Gene Testing Technology Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Noninvasive Prenatal Gene Testing Technology Market Size Market Share by Application (2017-2022)
3 Noninvasive Prenatal Gene Testing Technology Market Size by Player
- 3.1 Noninvasive Prenatal Gene Testing Technology Market Size Market Share by Players
- 3.1.1 Global Noninvasive Prenatal Gene Testing Technology Revenue by Players (2020-2022)
- 3.1.2 Global Noninvasive Prenatal Gene Testing Technology Revenue Market Share by Players (2020-2022)
- 3.2 Global Noninvasive Prenatal Gene Testing Technology Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Noninvasive Prenatal Gene Testing Technology by Regions
- 4.1 Noninvasive Prenatal Gene Testing Technology Market Size by Regions (2017-2022)
- 4.2 Americas Noninvasive Prenatal Gene Testing Technology Market Size Growth (2017-2022)
- 4.3 APAC Noninvasive Prenatal Gene Testing Technology Market Size Growth (2017-2022)
- 4.4 Europe Noninvasive Prenatal Gene Testing Technology Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Noninvasive Prenatal Gene Testing Technology Market Size by Country (2017-2022)
- 5.2 Americas Noninvasive Prenatal Gene Testing Technology Market Size by Type (2017-2022)
- 5.3 Americas Noninvasive Prenatal Gene Testing Technology Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Noninvasive Prenatal Gene Testing Technology Market Size by Region (2017-2022)
- 6.2 APAC Noninvasive Prenatal Gene Testing Technology Market Size by Type (2017-2022)
- 6.3 APAC Noninvasive Prenatal Gene Testing Technology Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Noninvasive Prenatal Gene Testing Technology by Country (2017-2022)
- 7.2 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Type (2017-2022)
- 7.3 Europe Noninvasive Prenatal Gene Testing Technology Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Noninvasive Prenatal Gene Testing Technology by Region (2017-2022)
- 8.2 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.1 Global Noninvasive Prenatal Gene Testing Technology Forecast by Regions (2023-2028)
- 10.1.1 Global Noninvasive Prenatal Gene Testing Technology Forecast by Regions (2023-2028)
- 10.1.2 Americas Noninvasive Prenatal Gene Testing Technology Forecast
- 10.1.3 APAC Noninvasive Prenatal Gene Testing Technology Forecast
- 10.1.4 Europe Noninvasive Prenatal Gene Testing Technology Forecast
- 10.1.5 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Forecast
- 10.2 Americas Noninvasive Prenatal Gene Testing Technology Forecast by Country (2023-2028)
- 10.2.1 United States Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.2.2 Canada Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.2.3 Mexico Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.2.4 Brazil Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3 APAC Noninvasive Prenatal Gene Testing Technology Forecast by Region (2023-2028)
- 10.3.1 China Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3.2 Japan Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3.3 Korea Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3.4 Southeast Asia Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3.5 India Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.3.6 Australia Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.4 Europe Noninvasive Prenatal Gene Testing Technology Forecast by Country (2023-2028)
- 10.4.1 Germany Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.4.2 France Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.4.3 UK Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.4.4 Italy Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.4.5 Russia Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.5 Middle East & Africa Noninvasive Prenatal Gene Testing Technology Forecast by Region (2023-2028)
- 10.5.1 Egypt Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.5.2 South Africa Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.5.3 Israel Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.5.4 Turkey Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.5.5 GCC Countries Noninvasive Prenatal Gene Testing Technology Market Forecast
- 10.6 Global Noninvasive Prenatal Gene Testing Technology Forecast by Type (2023-2028)
- 10.7 Global Noninvasive Prenatal Gene Testing Technology Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Illumina
- 11.1.1 Illumina Company Information
- 11.1.2 Illumina Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.1.3 Illumina Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Illumina Main Business Overview
- 11.1.5 Illumina Latest Developments
- 11.2 Natera
- 11.2.1 Natera Company Information
- 11.2.2 Natera Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.2.3 Natera Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Natera Main Business Overview
- 11.2.5 Natera Latest Developments
- 11.3 LifeLabs
- 11.3.1 LifeLabs Company Information
- 11.3.2 LifeLabs Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.3.3 LifeLabs Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 LifeLabs Main Business Overview
- 11.3.5 LifeLabs Latest Developments
- 11.4 NiftyTest
- 11.4.1 NiftyTest Company Information
- 11.4.2 NiftyTest Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.4.3 NiftyTest Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 NiftyTest Main Business Overview
- 11.4.5 NiftyTest Latest Developments
- 11.5 Labcorp
- 11.5.1 Labcorp Company Information
- 11.5.2 Labcorp Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.5.3 Labcorp Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Labcorp Main Business Overview
- 11.5.5 Labcorp Latest Developments
- 11.6 Xcelom
- 11.6.1 Xcelom Company Information
- 11.6.2 Xcelom Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.6.3 Xcelom Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Xcelom Main Business Overview
- 11.6.5 Xcelom Latest Developments
- 11.7 Veritas
- 11.7.1 Veritas Company Information
- 11.7.2 Veritas Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.7.3 Veritas Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Veritas Main Business Overview
- 11.7.5 Veritas Latest Developments
- 11.8 Sema4
- 11.8.1 Sema4 Company Information
- 11.8.2 Sema4 Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.8.3 Sema4 Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Sema4 Main Business Overview
- 11.8.5 Sema4 Latest Developments
- 11.9 CeGaT
- 11.9.1 CeGaT Company Information
- 11.9.2 CeGaT Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.9.3 CeGaT Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 CeGaT Main Business Overview
- 11.9.5 CeGaT Latest Developments
- 11.10 BGI
- 11.10.1 BGI Company Information
- 11.10.2 BGI Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.10.3 BGI Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 BGI Main Business Overview
- 11.10.5 BGI Latest Developments
- 11.11 Berry Genomics
- 11.11.1 Berry Genomics Company Information
- 11.11.2 Berry Genomics Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.11.3 Berry Genomics Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Berry Genomics Main Business Overview
- 11.11.5 Berry Genomics Latest Developments
- 11.12 Daan Gene
- 11.12.1 Daan Gene Company Information
- 11.12.2 Daan Gene Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.12.3 Daan Gene Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Daan Gene Main Business Overview
- 11.12.5 Daan Gene Latest Developments
- 11.13 CapitalBio
- 11.13.1 CapitalBio Company Information
- 11.13.2 CapitalBio Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.13.3 CapitalBio Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 CapitalBio Main Business Overview
- 11.13.5 CapitalBio Latest Developments
- 11.14 Annoroad
- 11.14.1 Annoroad Company Information
- 11.14.2 Annoroad Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.14.3 Annoroad Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Annoroad Main Business Overview
- 11.14.5 Annoroad Latest Developments
- 11.15 Adicon
- 11.15.1 Adicon Company Information
- 11.15.2 Adicon Noninvasive Prenatal Gene Testing Technology Product Offered
- 11.15.3 Adicon Noninvasive Prenatal Gene Testing Technology Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 Adicon Main Business Overview
- 11.15.5 Adicon Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Noninvasive Prenatal Gene Testing Technology. Industry analysis & Market Report on Noninvasive Prenatal Gene Testing Technology is a syndicated market report, published as Global Noninvasive Prenatal Gene Testing Technology Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Noninvasive Prenatal Gene Testing Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
